New Trends in Minor Tranquilizers

[1]  W. Sieghart,et al.  Molecular heterogeneity of benzodiazepine receptors , 1980, Nature.

[2]  H. Hatakeyama,et al.  Peptidoaminobenzophenones, a novel class of ring-opened derivatives of 1,4-benzoidazepines. , 1980, Journal of medicinal chemistry.

[3]  C. Olsen,et al.  Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Battersby,et al.  Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Beer,et al.  Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors , 1979, Pharmacology Biochemistry and Behavior.

[6]  E. Barnard,et al.  Putative benzodiazepine receptor: A protein solubilised from brain , 1979, FEBS letters.

[7]  M. Battersby,et al.  Benzodiazepine receptor: photoaffinity labeling and localization. , 1979, European journal of pharmacology.

[8]  J. Tallman,et al.  Solubilization of benzodiazepine binding site from rat cortex. , 1979, Life sciences.

[9]  B. Beer,et al.  Benzodiazepine receptors: Cellular and behavioral characteristics , 1979, Pharmacology Biochemistry and Behavior.

[10]  C. Braestrup,et al.  Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors , 1979, Pharmacology Biochemistry and Behavior.

[11]  S. Paul,et al.  Irazepine, a noncompetitive, irreversible inhibitor of 3H-diazepam binding to benzodiazepine receptors , 1979, Nature.

[12]  L. Pieri,et al.  Nicotinamide is a brain constituent with benzodiazepine-like actions , 1979, Nature.

[13]  Goldberg Hl,et al.  Comparative efficacy of tofisopam and placebo. , 1979 .

[14]  S. Spector,et al.  Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine-binding sites. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Weber,et al.  Heteroaromaten mit anellierten Siebenringen, III. Umwandlung von Thienotriazolooxazepinen in Diazepine , 1978 .

[16]  F. Goodwin,et al.  Demonstration of an endogenous, competitive inhibitor(s) of [3H] diazepam binding in bovine brain. , 1978, Life sciences.

[17]  R. I. Fryer,et al.  Quinazolines and 1,4‐benzodiazepines. LXXXV syntheses of 3‐substituted lmidazo[1,5‐a] [1,4]benzodiazepines , 1978 .

[18]  R. Schwartz,et al.  Quinazolines and 1,4-benzodiazepines. 84. Synthesis and reactions of imidazo[1,5-a][1,4]benzodiazepines , 1978 .

[19]  H. Mohler,et al.  Benzodiazepine receptor: demonstration in the central nervous system , 1977, Science.

[20]  C. Braestrup,et al.  Benzodiazepine receptors in rat brain , 1977, Nature.

[21]  R. Lahti,et al.  Conversion of N-alkylaminobenzophenones to benzodiazepines in vivo. , 1976, Journal of medicinal chemistry.

[22]  P. von Voigtlander,et al.  Central nervous system depressants. 13. s-Triazolo-1,5-benzodiazepin-5-ones. , 1976, Journal of medicinal chemistry.

[23]  H. Meyer,et al.  Mineral Inclusions in Diamond: Temperature and Pressure of Equilibration , 1976, Science.

[24]  K. Granville-Grossman.  Propranolol, anxiety and the central nervous system. , 1974, British journal of clinical pharmacology.

[25]  I. Nordin,et al.  Pyrazolodiazepines. 1,3-(And 2,3-) dialkyl-4,6-dihydro-8-arylpyrazolo(4,3-e)(1,4)diazepin-5-ones as antianxiety agents. , 1973, Journal of Medicinal Chemistry.

[26]  D. Hicks,et al.  Beta-adrenergic-receptor blockade with practolol in treatment of anxiety. , 1972, Lancet.

[27]  J. Hester,et al.  6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity. , 1971, Journal of medicinal chemistry.

[28]  H. Murata,et al.  Studies on the metabolism of oxazolam. II. Isolation and identification of the metabolites of oxazolam in rats. , 1971, Chemical & pharmaceutical bulletin.

[29]  C. Tamura,et al.  Anxiolytic sedatives. 1. Synthesis and pharmacology of benzo[6,7]-1,4-diazepino[5,4-b]oxazole derivatives and analogs. , 1971, Journal of medicinal chemistry.

[30]  T. L. Lemke,et al.  The synthesis of oxazolo- and oxazino[3,2-d] [1,4]benzodiazepinones , 1971 .

[31]  P. Turner,et al.  The effect of propranolol on anxiety. , 1966, Lancet.

[32]  L. Sternbach,et al.  Quinazolines and 1,4-Benzodiazepines. XI.1 Synthesis and Transformations of 7-Chloro-2,3-dihydro(and 2,3,4,5-tetrahydro)-5-phenyl-1H-1,4-benzodiazepine2 , 1963 .

[33]  L. Sternbach.  The benzodiazepine story. , 1983, Journal of psychoactive drugs.

[34]  C. Chidester,et al.  Synthesis and proof of structure of a novel 1,4-benzodiazepine , 1971 .

[35]  L. Sternbach,et al.  The reaction of epoxides with 1,4-benzodiazepines, mechanism and structural assignments , 1971 .

[36]  K. Meguro,et al.  Syntheses and structures of 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiazepines and some isomeric 1,4,5-benzotriazocines , 1970 .